Position in DTIL
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,227,473
-$130,671 QoQ
Shares Held
223,177
-31.6% QoQ
Ownership
0.865%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 78 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DTIL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,447,997,584 across 326 Biotechnology names. DTIL ranks #174 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,726,993 | $588,750,729 | |
| 2 | INCY |
Incyte Corp
|
3,651,532 | $343,682,191 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
5,682,783 | $229,072,982 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
421,688 | $188,300,559 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
819,374 | $154,902,654 | |
| 6 | GMAB |
Genmab A/S
|
4,414,550 | $118,442,376 | |
| 7 | INVA |
Innoviva, Inc.
|
4,055,632 | $94,496,225 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,036,495 | $64,988,236 |
All Filings in DTIL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,227,473 | 223,177 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,358,144 | 326,477 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,082,897 | 196,177 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $337,163 | 80,277 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $395,800 | 82,977 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $418,330 | 109,798 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $722,158 | 80,598 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $807,570 | 82,998 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,349,192 | 99,498 | Shares | Sole | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||